Posts

Showing posts with the label Nilotinib

Tasigna 200mg - Anticancer drugs | view uses, side effects and price | MHP

Image
NILOTINIB 200MG DESCRIPTION Nilotinib sold under the brand name Tasigna 200mg and its belongs to targeted cancer cells Tasigna 200mg tablet is anticancer drugs, which prohibits development of the cancer cells. Tasigna 200mg tablet   is a prescription medicine, which sold under the supervision of medical oncologist.  Tasigna 200mg tablet   is also belongs to the class of kinase inhibitors. TASIGNA 200mg TASIGNA INDICATION Tasigna 200mg tablet  is mainly indicated in the conditions like; Chronic and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included Imatinib in adult patients MECHANISM OF ACTION CML: chronic myelogenous leukemia is caused by BCR-ABL oncogene  Tasigna 200mg (nilotinib) is a kinase inhibitor, which prohibits BCR-ABL kinase activity.  Tasigna 200mg  link to the ATP-bounding site of BCR-ABL protein  Tasigna 200mg...

Tasigna 150mg - Anticancer drugs | view uses, side effects and price | MHP

Image
NILOTINIB 150MG DESCRIPTION Nilotinib sold under the brand name Tasigna 150mg tablet and its belongs to targeted cancer cells Tasigna is anticancer drugs, which prohibits development of the cancer cells. Tasigna 150mg  is a prescription medicine, which sold under the supervision of medical oncologist. Tasigna 150mg is also belongs to the class of kinase inhibitors. tasigna 150mg TASIGNA INDICATION Tasigna 150mg tablets is mainly indicated in the conditions like; Chronic and accelerated phase Philadelphia chromosome positive chronic myelogenous leukemia (Ph+ CML) resistant or intolerant to prior therapy that included Imatinib in adult patients MECHANISM OF ACTION CML: chronic myelogenous leukemia is caused by BCR-ABL oncogene Tasigna 150mg (nilotinib) is a kinase inhibitor, which prohibits BCR-ABL kinase activity. Tasigna 150mg tablet link to the ATP-bounding site of BCR-ABL protein Tasigna 150mg inhibits proliferation of murine leukemic cell lines and huma...